title: Global expression of prophage genes in Escherichia coli O157:H7 strain EDL933 in response to norfloxacin.
abstract: We investigated the influence of a low concentration of the gyrase inhibitor norfloxacin on the transcriptome of enterohemorrhagic Escherichia coli O157:H7 strain EDL933. For this purpose, we used a commercial DNA microarray containing oligonucleotides specific for E. coli O157:H7 strains EDL933 and RIMD0509952 and E. coli K-12 strain MG1655. Under the conditions applied, 5,963 spots (94% of all spots) could be analyzed. Among these, 118 spots (P < 0.05) indicated transcriptional upregulation and 122 spots (P < 0.05) indicated transcriptional downregulation of the E. coli genes present on the array. Eighty-five upregulated EDL933 genes were phage borne. Fifty-two of them could be ascribed to the Shiga toxin-encoding phages (Stx phages) BP-933W and CP-933V; the other 33 genes belonged to non-Stx prophage elements in the EDL933 genome. Genes present in the BP-933W prophage genome were induced most strongly up to 158-fold in the case of stxA(2) upon induction with norfloxacin. Twenty-two additional upregulated genes appeared to be E. coli O157:H7 strain RIMD0509952-specific phage elements, and the remaining 11 genes were related mainly to recombination and stress functions. Downregulation was indicated predominantly for genes responsible for bacterial primary metabolism, such as energy production, cell division, and amino acid biosynthesis. Interestingly, some genes present in the locus of enterocyte effacement appeared to be downregulated. The results of the study have shown that a low concentration of norfloxacin has profound effects on the transcriptome of E. coli O157:H7.
authors.affiliation: Institut für Medizinishe Mikrobioloie und Hygiene, Technische Universität Dresden, Dresden, Germany.
authors.forename: Sylvia
authors.initials: S
authors.lastname: Herold
authors.forename: Jutta
authors.initials: J
authors.lastname: Siebert
authors.forename: Andrea
authors.initials: A
authors.lastname: Huber
authors.forename: Herbert
authors.initials: H
authors.lastname: Schmidt
mesh_terms: D000890:Anti-Infective Agents / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D019453:Escherichia coli O157 / Q000187:drug effects* / Q000235:genetics* / Q000254:growth & development; D020869:Gene Expression Profiling; D015964:Gene Expression Regulation, Bacterial / Q000187:drug effects*; D009643:Norfloxacin / Q000494:pharmacology*; D020411:Oligonucleotide Array Sequence Analysis; D016133:Polymerase Chain Reaction; D039002:Prophages / Q000235:genetics*; D022621:Shiga Toxin / Q000096:biosynthesis
chemical_list: D000890:Anti-Infective Agents; D004791:Enzyme Inhibitors; D022621:Shiga Toxin; D009643:Norfloxacin
references.citation: Lancet Infect Dis. 2004 Feb;4(2):100-11
references.pmid: 14871635
references.citation: Pathol Biol (Paris). 1987 Dec;35(10 Pt 2):1370-6
references.pmid: 3325898
references.citation: Crit Rev Microbiol. 1982;9(2):101-38
references.pmid: 7042209
references.citation: N Engl J Med. 1983 Mar 24;308(12):681-5
references.pmid: 6338386
references.citation: Lancet. 1983 Sep 3;2(8349):573
references.pmid: 6136724
references.citation: J Infect Dis. 2000 Feb;181(2):664-70
references.pmid: 10669353
references.citation: Microbiology. 2000 May;146 ( Pt 5):1085-90
references.pmid: 10832635
references.citation: Annu Rev Biochem. 2000;69:183-215
references.pmid: 10966457
references.citation: Emerg Infect Dis. 2000 Sep-Oct;6(5):458-65
references.pmid: 10998375
references.citation: Mol Microbiol. 2000 Oct;38(2):368-80
references.pmid: 11069662
references.citation: Nature. 2001 Jan 25;409(6819):529-33
references.pmid: 11206551
references.citation: J Bacteriol. 2001 Mar;183(6):2081-5
references.pmid: 11222608
references.citation: DNA Res. 2001 Feb 28;8(1):11-22
references.pmid: 11258796
references.citation: Mol Microbiol. 1991 Aug;5(8):1817-22
references.pmid: 1766367
references.citation: Infection. 1992 Jan-Feb;20(1):25-9
references.pmid: 1563808
references.citation: J Bacteriol. 1992 Dec;174(23):7495-9
references.pmid: 1447124
references.citation: Mol Microbiol. 1993 Nov;10(3):473-81
references.pmid: 7968526
references.citation: Science. 1997 Sep 5;277(5331):1453-62
references.pmid: 9278503
references.citation: Microbiol Mol Biol Rev. 1997 Sep;61(3):377-92
references.pmid: 9293187
references.citation: Nat Biotechnol. 1997 Dec;15(13):1359-67
references.pmid: 9415887
references.citation: Clin Microbiol Rev. 1998 Jan;11(1):142-201
references.pmid: 9457432
references.citation: Mol Microbiol. 1998 Jun;28(6):1255-67
references.pmid: 9680214
references.citation: Eur J Clin Microbiol Infect Dis. 1998 Nov;17(11):761-6
references.pmid: 9923515
references.citation: Mol Microbiol. 1998 Dec;30(5):905-10
references.pmid: 9988468
references.citation: J Bacteriol. 1999 Mar;181(6):1767-78
references.pmid: 10074068
references.citation: J Bacteriol. 1999 Apr;181(7):2257-60
references.pmid: 10094706
references.citation: Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3807-12
references.pmid: 10097119
references.citation: Curr Microbiol. 1999 Aug;39(2):68-72
references.pmid: 10398829
references.citation: Appl Environ Microbiol. 1999 Sep;65(9):3855-61
references.pmid: 10473386
references.citation: Nucleic Acids Res. 1999 Oct 1;27(19):3821-35
references.pmid: 10481021
references.citation: Emerg Infect Dis. 1999 Sep-Oct;5(5):607-25
references.pmid: 10511517
references.citation: Can J Microbiol. 1999 Sep;45(9):732-9
references.pmid: 10526400
references.citation: J Bacteriol. 2001 Sep;183(17):5187-97
references.pmid: 11489873
references.citation: Bioessays. 2001 Aug;23(8):708-15
references.pmid: 11494319
references.citation: Pediatr Nephrol. 2001 Oct;16(10):823-39
references.pmid: 11605791
references.citation: J Bacteriol. 2002 May;184(9):2546-51
references.pmid: 11948171
references.citation: Mol Microbiol. 2002 Apr;44(1):89-105
references.pmid: 11967071
references.citation: Nucleic Acids Res. 2002 May 1;30(9):e36
references.pmid: 11972351
references.citation: Infect Immun. 2002 Aug;70(8):3985-93
references.pmid: 12117903
references.citation: Antimicrob Agents Chemother. 2002 Nov;46(11):3478-83
references.pmid: 12384353
references.citation: Annu Rev Genet. 2002;36:175-203
references.pmid: 12429691
references.citation: J Bacteriol. 2003 Jan;185(1):155-64
references.pmid: 12486052
references.citation: Mol Microbiol. 2003 Feb;47(4):879-89
references.pmid: 12581346
references.citation: J Mol Microbiol Biotechnol. 2003;5(2):105-22
references.pmid: 12736533
references.citation: Mol Microbiol. 2003 Jun;48(6):1633-45
references.pmid: 12791144
references.citation: J Bacteriol. 2003 Oct;185(20):6158-70
references.pmid: 14526028
references.citation: Curr Opin Microbiol. 2003 Oct;6(5):482-9
references.pmid: 14572541
references.citation: Genome Res. 2003 Nov;13(11):2435-43
references.pmid: 14597655
references.citation: Arzneimittelforschung. 1985;35(10):1600-3
references.pmid: 2934069
references.citation: Microbiol Rev. 1987 Jun;51(2):206-20
references.pmid: 3299029
references.citation: Infect Immun. 2004 Sep;72(9):5452-9
references.pmid: 15322044